Carcinoma In Situ

Observed

→ investigated in trials for

Letrozolesmall molecule

4 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Afimoxifenesmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Anastrozolesmall molecule

3 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Gemcitabinesmall molecule

3 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Exemestanesmall molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Hormone Therapy

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Lapatinibsmall molecule

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Metforminsmall molecule

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Mitomycinsmall_molecule

2 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Pembrolizumabmonoclonal_antibody

2 trials (2 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Trastuzumabmonoclonal antibody

2 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

5-Aminolevulinic Acid

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Abemaciclibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aldesleukinother

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Aromatase Inhibitor

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Bexarotenesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cemiplimabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Chloroquinesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Cyclophosphamidesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Durvalumabmonoclonal antibody

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Enfortumab Vedotinadc

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fludarabinesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Fluorouracilsmall molecule

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Imiquimodsmall_molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Methyl Aminolevulinatesmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Nadofaragene Firadenovecgene therapy

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Palbociclibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Ruxolitinibsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Toripalimabmonoclonal antibody

1 trials (1 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Valrubicinsmall_molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

→ investigated in trials for

Zoledronic Acidsmall molecule

1 trials (0 active) · roll-up of the cancer and its descendants

—

Observed

Carcinoma In Situ studied in …STUDIED_INderived10 of 274show all (up to 200)
→ studied in	NCT06833073Phase 2 · recruiting A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011) · condition mapped ONTOLOGY_EXACT · 274 trials mapped (92 active)	—	—	Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT04570956Phase 2 · terminated Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk · condition mapped ONTOLOGY_EXACT · 274 trials mapped (92 active)	—	—	Breast Lobular Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT07408856Phase 1 · recruiting CAN1012 in Pre-Malignant DCIS and LCIS · condition mapped ALIAS · 274 trials mapped (92 active)	—	—	Breast Lobular Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT07711847NA · recruiting Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy · condition mapped ALIAS · 274 trials mapped (92 active)	—	—	Breast Ductal Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT02620852NA · recruiting Women Informed to Screen Depending on Measures of Risk (Wisdom Study) · condition mapped ONTOLOGY_EXACT · 274 trials mapped (92 active)	—	—	Breast Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT04084730Phase 2 · recruiting Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer · condition mapped ALIAS · 274 trials mapped (92 active)	—	—	Breast Ductal Carcinoma In Situ, Low Grade	1	Observed	clinicaltrials	graph →
→ studied in	NCT03077841Phase 2/Phase 3 · suspended Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer · condition mapped ALIAS · 274 trials mapped (92 active)	—	—	Breast Ductal Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT05014139Phase 1 · terminated A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) · condition mapped ONTOLOGY_EXACT · 274 trials mapped (92 active)	—	—	Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT06033092Phase 2 · completed Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion · condition mapped ALIAS · 274 trials mapped (92 active)	—	—	Breast Lobular Carcinoma In Situ	1	Observed	clinicaltrials	graph →
→ studied in	NCT07764744NA · not yet recruiting Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic Variants · condition mapped ONTOLOGY_EXACT · 274 trials mapped (92 active)	—	—	Serous Tubal Intraepithelial Carcinoma	1	Observed	clinicaltrials	graph →

Carcinoma In Situ studied in …STUDIED_INderived10 of 274show all (up to 200)

→ studied in

NCT06833073Phase 2 · recruiting

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011) · condition mapped ONTOLOGY_EXACT · 274 trials mapped (92 active)

—

Observed

Breast Lobular Carcinoma In Situ

→ studied in

NCT04570956Phase 2 · terminated

Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk · condition mapped ONTOLOGY_EXACT · 274 trials mapped (92 active)

—

Observed

Breast Lobular Carcinoma In Situ

→ studied in

NCT07408856Phase 1 · recruiting

CAN1012 in Pre-Malignant DCIS and LCIS · condition mapped ALIAS · 274 trials mapped (92 active)

—

Observed

Breast Ductal Carcinoma In Situ

→ studied in

NCT07711847NA · recruiting

Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy · condition mapped ALIAS · 274 trials mapped (92 active)

—

Observed

→ studied in

NCT02620852NA · recruiting

Women Informed to Screen Depending on Measures of Risk (Wisdom Study) · condition mapped ONTOLOGY_EXACT · 274 trials mapped (92 active)

—

Breast Carcinoma In Situ

Observed

Breast Ductal Carcinoma In Situ, Low Grade

→ studied in

NCT04084730Phase 2 · recruiting

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer · condition mapped ALIAS · 274 trials mapped (92 active)

—

Observed

Breast Ductal Carcinoma In Situ

→ studied in

NCT03077841Phase 2/Phase 3 · suspended

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer · condition mapped ALIAS · 274 trials mapped (92 active)

—

Observed

→ studied in

NCT05014139Phase 1 · terminated

A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) · condition mapped ONTOLOGY_EXACT · 274 trials mapped (92 active)

—

Observed

Breast Lobular Carcinoma In Situ

→ studied in

NCT06033092Phase 2 · completed

Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion · condition mapped ALIAS · 274 trials mapped (92 active)

—

Observed

Serous Tubal Intraepithelial Carcinoma

→ studied in

NCT07764744NA · not yet recruiting

Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic Variants · condition mapped ONTOLOGY_EXACT · 274 trials mapped (92 active)

—

Observed